Eli Lilly
Eli Lilly to acquire Loxo Oncology for $8 bn in cash
09 Jan 2019
Loxo’s oncology drug Vitrakvi, priced at $32,800 per month, and experimental follow-up drug LOXO-195, on which Bayer is also a partner, together could generate annual sales of about $750 million
Eli Lilly to buy Armo BioSciences for $1.6 bn
11 May 2018
US pharmaceutical company Eli Lilly and Co yesterday struck a deal to buy Armo BioSciences Inc for about $1.6 billion in order to strengthen its immuno-oncology portfolio
Eli Lilly wins key cancer drug patent case in UK
26 Jun 2015
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
